GHTC signed a Defense Health Research Consortium (DHRC) letter to Congress urging enactment of the fiscal year 2022 (FY22) Defense Appropriations Act to ensure that the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs, are fully funded in FY22.PDF
GHTC’s director Jamie Bay Nishi was invited by the White House to deliver video remarks for the Global COVID-19 Summit held on September 22, 2021.Learn more
GHTC Director Jamie Bay Nishi was interviewed as part of a Mediaplanet campaign on neglected tropical diseases (NTDs) that was featured in the Guardian.View
The Infectious Diseases Society of America (ISDA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, prevention, and patient care. The society, which has nearly 10,000 members, was founded in 1963 and is based in Arlington, VA.VIEW
Why we're needed
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.Learn More
GHTC endorsed two letters from the Global Health Council's Tuberculosis (TB) Roundtable to the White House Office of Management and Budget urging support for domestic and global TB programs in the fiscal year 2023 budget.Learn more
GHTC Multilateral Policy and Advocacy Officer Philip Kenol was selected as a finalist for Washington Global Health Alliance's (WGHA) Rising Star Award, which recognizes an individual age 40 or under who is making an exceptional impact in a global health organization or initiative.Learn more
ANOTHER TRIUMPH OF SCIENCE, BUT DEFEAT FOR ACCESS? Ensuring innovation and equitable access for COVID-19 treatments and other pandemics
Drugs for Neglected Diseases initiative
Triangle Global Health Consortium
Last month, G20 health ministers released their annual declaration, emphasizing support for multilateral cooperation to end the COVID-19 pandemic and improving access to COVID-19 medical countermeasures. In this blog, GHTC looks back on G20 commitments from previous years and reflects on how the declarations have evolved and what they have been missing.
Research Roundup: A malaria vaccine recommendation, potential dengue drug, and African health agency
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Increasing access to malaria interventions for adolescent girls is an important step toward malaria elimination
While gains have been made in global malaria control, little progress has been made in reducing malaria-related deaths among adolescents. The protection of populations such as adolescents, and particularly girls, has been largely overlooked—despite malaria being one of the major causes of death and ill health in these populations.